United States· US:42385-929_80228c3a-152e-4170-9469-b4e13b137bcb
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
A lamivudine, tenofovir disoproxil and efavirenz product containing efavirenz; lamivudine; tenofovir disoproxil fumarate, registered in United States by Laurus Labs Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Manufacturer
- Laurus Labs Limited
- Country
- United States (US)
- ATC code
- J05AR11
- ATC class
- Lamivudine, tenofovir disoproxil and efavirenz
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 12
- ndc114238592918180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)
- ndc11423859293030 TABLET, FILM COATED in 1 BOTTLE (42385-929-30)
- ndc11423859293130 TABLET, FILM COATED in 1 BOTTLE (42385-929-31)
- ndc114238592982180 TABLET, FILM COATED in 1 BOTTLE (42385-929-82)
- ndc11423859299090 TABLET, FILM COATED in 1 BOTTLE (42385-929-90)
- ndc11423859299190 TABLET, FILM COATED in 1 BOTTLE (42385-929-91)
- ndc1142385-929-18
- ndc1142385-929-30
- ndc1142385-929-31
- ndc1142385-929-82
- ndc1142385-929-90
- ndc1142385-929-91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J05AR11
Lamivudine, tenofovir disoproxil and efavirenz, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79aa8b59-0a47-43f2-89c1-0fa7d561bb84 GET /v1/drugs/79aa8b59-0a47-43f2-89c1-0fa7d561bb84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "400; 300; 300",
"substance": "EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE",
"productndc": "42385-929",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1",
"application_number": "ANDA213038",
"marketing_category": "ANDA"
}See everything about lamivudine, tenofovir disoproxil and efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.